Alaunos Therapeutics, Inc. (TCRT) Insider Ownership

Historic Insider Ownership Trends

TCRT's three largest insider shareholders as of March 23, 2026 are Robert W Postma (Director, 5.45Mn shares), Robert W Postma (Director, 5.00Mn shares), Jaime Vieser (Director, 1.25Mn shares).

Top Direct Holders

Insider ownership data is derived from the last 60 months of Form 4 SEC filings.
Holder Position Shares (Direct) Shares (Indirect) Report Date
Robert W Postma 1,201,870 4,250,000 03 Sep, 2021
Robert W Postma 0 5,000,000 01 Dec, 2022
Jaime Vieser 0 1,250,000 01 Dec, 2022
Kevin S. Sr. Boyle Chief Executive Officer 885,000 0 17 Nov, 2021
Kevin S. Sr. Boyle Chief Executive Officer 798,236 0 05 Sep, 2023
Jaime Vieser 705,321 0 04 Oct, 2021
Raffaele Baffa Chief Medical Officer 280,645 0 19 May, 2021
Groot Eleanor De Evp, Operations 237,106 0 27 Dec, 2021
James Huang 188,333 0 24 Jun, 2022
Holger Weis 160,167 0 24 Jun, 2022
Heidi Hagen 145,889 0 03 Sep, 2021
Holger Weis 120,167 0 03 Sep, 2021
James Huang 108,333 0 03 Sep, 2021
Mary Thistle 45,000 0 24 Jun, 2022
Christopher Bowden 44,167 0 24 Jun, 2022
Robert W Postma 43,872 0 15 Jan, 2026
Jaime Vieser 32,338 0 15 Jan, 2026
Ferdinand Groenewald Vice President Of Finance 10,775 0 20 Aug, 2025
Michael Allen Jerman 9,589 0 15 Jan, 2025
Mary Thistle 5,000 0 06 May, 2021
Christopher Bowden 4,167 0 06 May, 2021
J Kevin Buchi 4,167 0 06 May, 2021

* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.

Recent Insider Transactions

Detailed insider trading activity based on Form 4 SEC filings.
Download Data
Transaction Date Insider Name Security Class Transaction Type Shares Traded Price Shares Remaining Ownership Code
12 Jan, 2026 Robert W Postma Common Stock A 5,622 $2.89 43,872 D A
12 Jan, 2026 Jaime Vieser Common Stock A 5,839 $2.89 32,338 D A
21 Nov, 2025 Jaime Vieser Common Stock A 5,340 $3.16 26,499 D A
21 Nov, 2025 Robert W Postma Common Stock A 5,142 $3.16 38,250 D A
21 Nov, 2025 Michael Allen Jerman Common Stock A 4,183 $3.16 4,183 D A
18 Aug, 2025 Holger Weis Employee Stock Option (right to buy) A 13,676 $0.00 13,676 D A
18 Aug, 2025 Ferdinand Groenewald Common Stock A 10,775 $0.00 10,775 D A
18 Aug, 2025 Ferdinand Groenewald Employee Stock Option (right to buy) A 4,000 $0.00 4,000 D A
15 Jul, 2025 Michael Allen Jerman Employee Stock Option (right to buy) A 10,000 $0.00 10,000 D A
15 Jul, 2025 Michael Allen Jerman Employee Stock Option (right to buy) A 3,200 $0.00 3,200 D A
02 Jul, 2025 Holger Weis Employee Stock Option (right to buy) A 130,000 $0.00 130,000 D A
03 Jul, 2025 Jaime Vieser Common Stock A 3,400 $0.00 21,159 D A
03 Jul, 2025 Robert W Postma Common Stock A 4,050 $0.00 33,133 D A
03 Jul, 2025 Robert W Postma Employee Stock Option (right to buy) A 6,400 $0.00 6,400 D A
03 Jul, 2025 Jaime Vieser Employee Stock Option (right to buy) A 6,400 $0.00 6,400 D A
24 Jun, 2025 Jaime Vieser Series A-2 Convertible Preferred Stock A 250 $4.49 250 D P
13 Apr, 2025 Robert W Postma Common Stock A 20,804 $2.92 29,083 D A
11 Apr, 2025 Robert W Postma Series A-1 Convertible Preferred Stock A 500 $2.76 500 I P
24 Jun, 2025 Robert W Postma Series A-2 Convertible Preferred Stock A 600 $4.49 600 I P
13 Apr, 2025 Holger Weis Employee Stock Option (right to buy) A 10,904 $0.00 10,904 D A